Variable | Culprit lesions in UAP | p Value | Non-culprit lesions in UAP | p Value | Lesions in SAP | p Value | |||
NV (n=32) | No NV (n=60) | NV (n=70) | No NV (n=133) | NV (n=17) | No NV (n=44) | ||||
Men, n (%) | 25 (78) | 42 (70) | 0.40 | 52 (74) | 89 (67) | 0.28 | 10 (59) | 29 (66) | 0.61 |
Age, years | 57±11 | 58±8 | 0.66 | 59±8 | 58±9 | 0.39 | 54±7 | 55±8 | 0.44 |
Smoker, n (%) | 18 (56) | 30 (50) | 0.57 | 47 (67) | 66 (50) | 0.02 | 8 (47) | 16 (36) | 0.44 |
Hypertension, n (%) | 19 (59) | 31 (52) | 0.48 | 43 (61) | 70 (53) | 0.23 | 12 (71) | 25 (57) | 0.32 |
Dyslipidaemia, n (%) | 17 (53) | 35 (58) | 0.63 | 32 (45) | 69 (52) | 0.40 | 9 (53) | 23 (52) | 0.96 |
Diabetes, n (%) | 9 (28) | 20 (33) | 0.61 | 34 (49) | 54 (41) | 0.28 | 7 (41) | 14 (32) | 0.49 |
Family history | 7 (22) | 19 (32) | 0.32 | 20 (29) | 35 (26) | 0.73 | 5 (29) | 15 (34) | 0.73 |
Medications | |||||||||
Aspirin, n (%) | 31 (97) | 59 (98) | 1.00 | 68 (97) | 131 (99) | 0.61 | 16 (94) | 37 (84) | 0.54 |
Clopidogrel, n (%) | 28 (88) | 53 (88) | 1.00 | 65 (93) | 125 (94) | 0.99 | 12 (71) | 35 (80) | 0.68 |
Statin, n (%) | 31 (97) | 53 (88) | 0.32 | 60 (86) | 113 (85) | 0.87 | 15 (88) | 42 (96) | 0.31 |
ACEI or ARB, n (%) | 18 (56) | 28 (47) | 0.38 | 36 (51) | 62 (47) | 0.51 | 9 (53%) | 20 (46) | 0.60 |
Data are presented as mean ±SD, n (%).
ACEI, ACE inhibitor; ARB, angiotensin II receptor blockers; NV, neovascularisation; SAP, stable angina pectoris; UAP, unstable angina pectoris; SAP, stable angina pectoris.